nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—EGFR—asthma	0.2	0.758	CbGaD
Erlotinib—ALB—asthma	0.0638	0.242	CbGaD
Erlotinib—UGT1A1—Indacaterol—asthma	0.0411	0.0914	CbGbCtD
Erlotinib—SLCO2B1—Montelukast—asthma	0.0294	0.0653	CbGbCtD
Erlotinib—CYP1B1—Theophylline—asthma	0.0268	0.0596	CbGbCtD
Erlotinib—CYP1A1—Isoprenaline—asthma	0.0165	0.0367	CbGbCtD
Erlotinib—ABCG2—Zafirlukast—asthma	0.0165	0.0367	CbGbCtD
Erlotinib—CYP1A1—Theophylline—asthma	0.0117	0.0261	CbGbCtD
Erlotinib—CYP3A5—Beclomethasone—asthma	0.0116	0.0259	CbGbCtD
Erlotinib—CYP3A5—Salmeterol—asthma	0.0116	0.0259	CbGbCtD
Erlotinib—CYP2C8—Salmeterol—asthma	0.0112	0.0249	CbGbCtD
Erlotinib—CYP2C8—Mometasone—asthma	0.0112	0.0249	CbGbCtD
Erlotinib—ABCB1—Fluticasone furoate—asthma	0.00999	0.0222	CbGbCtD
Erlotinib—CYP3A5—Fluticasone Propionate—asthma	0.00989	0.022	CbGbCtD
Erlotinib—CYP2C8—Zafirlukast—asthma	0.00878	0.0195	CbGbCtD
Erlotinib—CYP1B1—Dexamethasone—asthma	0.00878	0.0195	CbGbCtD
Erlotinib—ABCB1—Indacaterol—asthma	0.00815	0.0181	CbGbCtD
Erlotinib—CYP1A2—Zileuton—asthma	0.00772	0.0172	CbGbCtD
Erlotinib—CYP2D6—Ciclesonide—asthma	0.00768	0.0171	CbGbCtD
Erlotinib—CYP1A2—Zafirlukast—asthma	0.0068	0.0151	CbGbCtD
Erlotinib—CYP2C8—Theophylline—asthma	0.00678	0.0151	CbGbCtD
Erlotinib—ABCG2—Hydrocortisone—asthma	0.00671	0.0149	CbGbCtD
Erlotinib—CYP2C8—Montelukast—asthma	0.00643	0.0143	CbGbCtD
Erlotinib—CYP2C8—Loratadine—asthma	0.00643	0.0143	CbGbCtD
Erlotinib—CYP2D6—Ipratropium bromide—asthma	0.00636	0.0141	CbGbCtD
Erlotinib—CYP3A4—Fluticasone furoate—asthma	0.00599	0.0133	CbGbCtD
Erlotinib—CYP2D6—Zafirlukast—asthma	0.0056	0.0125	CbGbCtD
Erlotinib—CYP1A2—Aminophylline—asthma	0.00558	0.0124	CbGbCtD
Erlotinib—CYP2D6—Arformoterol—asthma	0.00541	0.012	CbGbCtD
Erlotinib—CYP2D6—Formoterol—asthma	0.00541	0.012	CbGbCtD
Erlotinib—CYP3A4—Budesonide—asthma	0.00534	0.0119	CbGbCtD
Erlotinib—CYP1A2—Theophylline—asthma	0.00525	0.0117	CbGbCtD
Erlotinib—CYP3A4—Ciclesonide—asthma	0.00488	0.0109	CbGbCtD
Erlotinib—CYP3A4—Indacaterol—asthma	0.00488	0.0109	CbGbCtD
Erlotinib—CYP2D6—Tiotropium—asthma	0.00482	0.0107	CbGbCtD
Erlotinib—ALB—Prednisone—asthma	0.00461	0.0103	CbGbCtD
Erlotinib—CYP3A4—Salbutamol—asthma	0.00454	0.0101	CbGbCtD
Erlotinib—CYP3A4—Flunisolide—asthma	0.00454	0.0101	CbGbCtD
Erlotinib—CYP3A4—Salmeterol—asthma	0.00454	0.0101	CbGbCtD
Erlotinib—ABCB1—Loratadine—asthma	0.00435	0.00968	CbGbCtD
Erlotinib—CYP2D6—Theophylline—asthma	0.00432	0.00962	CbGbCtD
Erlotinib—ABCG2—Dexamethasone—asthma	0.00417	0.00928	CbGbCtD
Erlotinib—CYP2D6—Loratadine—asthma	0.0041	0.00912	CbGbCtD
Erlotinib—CYP3A4—Zileuton—asthma	0.00404	0.009	CbGbCtD
Erlotinib—CYP3A4—Ipratropium bromide—asthma	0.00404	0.009	CbGbCtD
Erlotinib—ABCB1—Methylprednisolone—asthma	0.00398	0.00885	CbGbCtD
Erlotinib—CYP3A4—Fluticasone Propionate—asthma	0.00386	0.00858	CbGbCtD
Erlotinib—CYP1A1—Dexamethasone—asthma	0.00385	0.00857	CbGbCtD
Erlotinib—CYP3A5—Hydrocortisone—asthma	0.00372	0.00827	CbGbCtD
Erlotinib—CYP2C8—Hydrocortisone—asthma	0.00357	0.00795	CbGbCtD
Erlotinib—CYP3A4—Zafirlukast—asthma	0.00356	0.00792	CbGbCtD
Erlotinib—CYP3A4—Tiotropium—asthma	0.00306	0.00682	CbGbCtD
Erlotinib—CYP3A4—Aminophylline—asthma	0.00292	0.0065	CbGbCtD
Erlotinib—CYP3A4—Theophylline—asthma	0.00275	0.00612	CbGbCtD
Erlotinib—CYP3A4—Montelukast—asthma	0.00261	0.0058	CbGbCtD
Erlotinib—CYP3A4—Loratadine—asthma	0.00261	0.0058	CbGbCtD
Erlotinib—ABCB1—Betamethasone—asthma	0.00259	0.00575	CbGbCtD
Erlotinib—ABCB1—Prednisolone—asthma	0.00255	0.00568	CbGbCtD
Erlotinib—ABCB1—Hydrocortisone—asthma	0.00242	0.00538	CbGbCtD
Erlotinib—ABCB1—Prednisone—asthma	0.00241	0.00536	CbGbCtD
Erlotinib—CYP3A4—Methylprednisolone—asthma	0.00238	0.0053	CbGbCtD
Erlotinib—CYP3A5—Dexamethasone—asthma	0.00231	0.00514	CbGbCtD
Erlotinib—CYP2C8—Dexamethasone—asthma	0.00222	0.00495	CbGbCtD
Erlotinib—ORM1—saliva—asthma	0.00222	0.0451	CbGeAlD
Erlotinib—CYP3A4—Triamcinolone—asthma	0.00181	0.00402	CbGbCtD
Erlotinib—CYP3A4—Betamethasone—asthma	0.00155	0.00345	CbGbCtD
Erlotinib—CYP3A4—Prednisolone—asthma	0.00153	0.0034	CbGbCtD
Erlotinib—ABCB1—Dexamethasone—asthma	0.0015	0.00335	CbGbCtD
Erlotinib—CYP3A4—Hydrocortisone—asthma	0.00145	0.00323	CbGbCtD
Erlotinib—CYP3A4—Prednisone—asthma	0.00144	0.00321	CbGbCtD
Erlotinib—CYP2D6—Dexamethasone—asthma	0.00142	0.00315	CbGbCtD
Erlotinib—MAP3K19—respiratory system—asthma	0.00139	0.0282	CbGeAlD
Erlotinib—MKNK1—Pindolol—Isoprenaline—asthma	0.00127	1	CbGdCrCtD
Erlotinib—FLT3—respiratory system—asthma	0.00121	0.0245	CbGeAlD
Erlotinib—TNK1—bronchus—asthma	0.00116	0.0234	CbGeAlD
Erlotinib—TNK1—trachea—asthma	0.00104	0.0211	CbGeAlD
Erlotinib—LTK—lung—asthma	0.00102	0.0206	CbGeAlD
Erlotinib—AURKC—adrenal gland—asthma	0.001	0.0203	CbGeAlD
Erlotinib—JAK3—adrenal gland—asthma	0.000926	0.0188	CbGeAlD
Erlotinib—FLT3—cardiovascular system—asthma	0.000924	0.0187	CbGeAlD
Erlotinib—PIP4K2C—adrenal cortex—asthma	0.000914	0.0186	CbGeAlD
Erlotinib—CYP3A4—Dexamethasone—asthma	0.000901	0.00201	CbGbCtD
Erlotinib—PIP4K2C—bronchus—asthma	0.000897	0.0182	CbGeAlD
Erlotinib—ULK3—adrenal cortex—asthma	0.000873	0.0177	CbGeAlD
Erlotinib—ULK3—bronchus—asthma	0.000856	0.0174	CbGeAlD
Erlotinib—TNK1—adrenal gland—asthma	0.00085	0.0173	CbGeAlD
Erlotinib—MKNK1—adrenal cortex—asthma	0.000822	0.0167	CbGeAlD
Erlotinib—JAK3—lung—asthma	0.000812	0.0165	CbGeAlD
Erlotinib—STK10—respiratory system—asthma	0.000806	0.0164	CbGeAlD
Erlotinib—MKNK1—bronchus—asthma	0.000806	0.0164	CbGeAlD
Erlotinib—PIP4K2C—trachea—asthma	0.000805	0.0163	CbGeAlD
Erlotinib—SLK—adrenal cortex—asthma	0.000778	0.0158	CbGeAlD
Erlotinib—ULK3—trachea—asthma	0.000769	0.0156	CbGeAlD
Erlotinib—SLK—bronchus—asthma	0.000763	0.0155	CbGeAlD
Erlotinib—MKNK1—cardiovascular system—asthma	0.00075	0.0152	CbGeAlD
Erlotinib—TNK1—lung—asthma	0.000745	0.0151	CbGeAlD
Erlotinib—MAP3K19—lung—asthma	0.000738	0.015	CbGeAlD
Erlotinib—Vandetanib—VEGFA—asthma	0.000733	0.315	CrCbGaD
Erlotinib—FLT3—adrenal gland—asthma	0.000731	0.0148	CbGeAlD
Erlotinib—ABL2—adrenal gland—asthma	0.000698	0.0142	CbGeAlD
Erlotinib—SLK—trachea—asthma	0.000685	0.0139	CbGeAlD
Erlotinib—EGFR—adrenal gland—asthma	0.000681	0.0138	CbGeAlD
Erlotinib—STK10—bronchus—asthma	0.000664	0.0135	CbGeAlD
Erlotinib—PIP4K2C—adrenal gland—asthma	0.00066	0.0134	CbGeAlD
Erlotinib—FLT3—lung—asthma	0.00064	0.013	CbGeAlD
Erlotinib—ULK3—adrenal gland—asthma	0.00063	0.0128	CbGeAlD
Erlotinib—Vandetanib—EGFR—asthma	0.000619	0.266	CrCbGaD
Erlotinib—STK10—cardiovascular system—asthma	0.000617	0.0125	CbGeAlD
Erlotinib—ABL2—lung—asthma	0.000611	0.0124	CbGeAlD
Erlotinib—MAP2K5—adrenal cortex—asthma	0.000604	0.0123	CbGeAlD
Erlotinib—EGFR—lung—asthma	0.000597	0.0121	CbGeAlD
Erlotinib—MKNK1—adrenal gland—asthma	0.000593	0.012	CbGeAlD
Erlotinib—MAP2K5—bronchus—asthma	0.000593	0.012	CbGeAlD
Erlotinib—Gefitinib—EGFR—asthma	0.000588	0.253	CrCbGaD
Erlotinib—PIP4K2C—lung—asthma	0.000578	0.0117	CbGeAlD
Erlotinib—SLK—adrenal gland—asthma	0.000562	0.0114	CbGeAlD
Erlotinib—SLCO2B1—respiratory system—asthma	0.00056	0.0114	CbGeAlD
Erlotinib—ABL1—respiratory system—asthma	0.000555	0.0113	CbGeAlD
Erlotinib—ULK3—lung—asthma	0.000552	0.0112	CbGeAlD
Erlotinib—MAP2K5—cardiovascular system—asthma	0.000551	0.0112	CbGeAlD
Erlotinib—MAP2K5—trachea—asthma	0.000532	0.0108	CbGeAlD
Erlotinib—MKNK1—lung—asthma	0.00052	0.0106	CbGeAlD
Erlotinib—SLK—lung—asthma	0.000492	0.00999	CbGeAlD
Erlotinib—STK10—adrenal gland—asthma	0.000488	0.00991	CbGeAlD
Erlotinib—CYP1B1—respiratory system—asthma	0.00047	0.00955	CbGeAlD
Erlotinib—ABL1—adrenal cortex—asthma	0.000466	0.00946	CbGeAlD
Erlotinib—ABL1—bronchus—asthma	0.000457	0.00928	CbGeAlD
Erlotinib—ABL1—smooth muscle tissue—asthma	0.000447	0.00908	CbGeAlD
Erlotinib—MAP2K5—adrenal gland—asthma	0.000436	0.00885	CbGeAlD
Erlotinib—STK10—lung—asthma	0.000428	0.00869	CbGeAlD
Erlotinib—ABL1—cardiovascular system—asthma	0.000425	0.00863	CbGeAlD
Erlotinib—ABL1—trachea—asthma	0.00041	0.00833	CbGeAlD
Erlotinib—MAP2K5—lung—asthma	0.000382	0.00776	CbGeAlD
Erlotinib—CYP1B1—smooth muscle tissue—asthma	0.000379	0.00769	CbGeAlD
Erlotinib—CYP1B1—cardiovascular system—asthma	0.00036	0.00731	CbGeAlD
Erlotinib—SLCO2B1—adrenal gland—asthma	0.000339	0.00689	CbGeAlD
Erlotinib—CYP1A2—respiratory system—asthma	0.000337	0.00684	CbGeAlD
Erlotinib—ABL1—adrenal gland—asthma	0.000336	0.00683	CbGeAlD
Erlotinib—CYP1A1—respiratory system—asthma	0.000333	0.00675	CbGeAlD
Erlotinib—CYP3A5—respiratory system—asthma	0.000325	0.0066	CbGeAlD
Erlotinib—ALB—adrenal gland—asthma	0.000311	0.0063	CbGeAlD
Erlotinib—ORM1—lung—asthma	0.00031	0.0063	CbGeAlD
Erlotinib—SLCO2B1—lung—asthma	0.000297	0.00604	CbGeAlD
Erlotinib—ABL1—lung—asthma	0.000295	0.00599	CbGeAlD
Erlotinib—ABCG2—adrenal cortex—asthma	0.000294	0.00597	CbGeAlD
Erlotinib—CYP1B1—adrenal gland—asthma	0.000285	0.00578	CbGeAlD
Erlotinib—CYP1A1—epithelium—asthma	0.000278	0.00564	CbGeAlD
Erlotinib—CYP1A1—bronchus—asthma	0.000274	0.00555	CbGeAlD
Erlotinib—CYP1B1—lung—asthma	0.00025	0.00507	CbGeAlD
Erlotinib—CYP1A1—trachea—asthma	0.000246	0.00499	CbGeAlD
Erlotinib—ABCG2—adrenal gland—asthma	0.000212	0.00431	CbGeAlD
Erlotinib—Vandetanib—ALB—asthma	0.000197	0.0848	CrCbGaD
Erlotinib—Gefitinib—ALB—asthma	0.000187	0.0806	CrCbGaD
Erlotinib—ABCG2—lung—asthma	0.000186	0.00377	CbGeAlD
Erlotinib—CYP1A2—lung—asthma	0.000179	0.00363	CbGeAlD
Erlotinib—CYP1A1—lung—asthma	0.000177	0.00358	CbGeAlD
Erlotinib—ABCB1—respiratory system—asthma	0.000173	0.00351	CbGeAlD
Erlotinib—CYP3A5—lung—asthma	0.000173	0.0035	CbGeAlD
Erlotinib—ABCB1—adrenal cortex—asthma	0.000145	0.00294	CbGeAlD
Erlotinib—ABCB1—epithelium—asthma	0.000144	0.00293	CbGeAlD
Erlotinib—ABCB1—cardiovascular system—asthma	0.000132	0.00268	CbGeAlD
Erlotinib—ABCB1—trachea—asthma	0.000128	0.00259	CbGeAlD
Erlotinib—ABCB1—adrenal gland—asthma	0.000105	0.00212	CbGeAlD
Erlotinib—ABCB1—lung—asthma	9.17e-05	0.00186	CbGeAlD
Erlotinib—Dizziness—Formoterol—asthma	5.16e-05	0.000358	CcSEcCtD
Erlotinib—Dizziness—Arformoterol—asthma	5.16e-05	0.000358	CcSEcCtD
Erlotinib—Asthenia—Budesonide—asthma	5.12e-05	0.000355	CcSEcCtD
Erlotinib—Eye disorder—Methylprednisolone—asthma	5.1e-05	0.000354	CcSEcCtD
Erlotinib—Mental disorder—Hydrocortisone—asthma	5.09e-05	0.000353	CcSEcCtD
Erlotinib—Erythema—Hydrocortisone—asthma	5.06e-05	0.000351	CcSEcCtD
Erlotinib—Malnutrition—Hydrocortisone—asthma	5.06e-05	0.000351	CcSEcCtD
Erlotinib—Dizziness—Montelukast—asthma	5.06e-05	0.00035	CcSEcCtD
Erlotinib—Neutropenia—Prednisone—asthma	5.05e-05	0.00035	CcSEcCtD
Erlotinib—Pruritus—Budesonide—asthma	5.05e-05	0.00035	CcSEcCtD
Erlotinib—Diarrhoea—Salbutamol—asthma	5.04e-05	0.00035	CcSEcCtD
Erlotinib—Haemoglobin—Dexamethasone—asthma	4.99e-05	0.000346	CcSEcCtD
Erlotinib—Haemoglobin—Betamethasone—asthma	4.99e-05	0.000346	CcSEcCtD
Erlotinib—Haemorrhage—Betamethasone—asthma	4.97e-05	0.000344	CcSEcCtD
Erlotinib—Haemorrhage—Dexamethasone—asthma	4.97e-05	0.000344	CcSEcCtD
Erlotinib—Vomiting—Formoterol—asthma	4.96e-05	0.000344	CcSEcCtD
Erlotinib—Vomiting—Arformoterol—asthma	4.96e-05	0.000344	CcSEcCtD
Erlotinib—Nausea—Mometasone—asthma	4.94e-05	0.000342	CcSEcCtD
Erlotinib—Rash—Arformoterol—asthma	4.92e-05	0.000341	CcSEcCtD
Erlotinib—Rash—Formoterol—asthma	4.92e-05	0.000341	CcSEcCtD
Erlotinib—Mediastinal disorder—Methylprednisolone—asthma	4.92e-05	0.000341	CcSEcCtD
Erlotinib—Dermatitis—Arformoterol—asthma	4.92e-05	0.000341	CcSEcCtD
Erlotinib—Dermatitis—Formoterol—asthma	4.92e-05	0.000341	CcSEcCtD
Erlotinib—Headache—Arformoterol—asthma	4.89e-05	0.000339	CcSEcCtD
Erlotinib—Headache—Formoterol—asthma	4.89e-05	0.000339	CcSEcCtD
Erlotinib—Arrhythmia—Triamcinolone—asthma	4.89e-05	0.000339	CcSEcCtD
Erlotinib—Weight decreased—Prednisone—asthma	4.89e-05	0.000339	CcSEcCtD
Erlotinib—Diarrhoea—Budesonide—asthma	4.89e-05	0.000339	CcSEcCtD
Erlotinib—Arrhythmia—Methylprednisolone—asthma	4.88e-05	0.000338	CcSEcCtD
Erlotinib—Dizziness—Salbutamol—asthma	4.87e-05	0.000338	CcSEcCtD
Erlotinib—Vomiting—Montelukast—asthma	4.86e-05	0.000337	CcSEcCtD
Erlotinib—Rash—Montelukast—asthma	4.82e-05	0.000334	CcSEcCtD
Erlotinib—Dermatitis—Montelukast—asthma	4.82e-05	0.000334	CcSEcCtD
Erlotinib—Depression—Prednisone—asthma	4.8e-05	0.000333	CcSEcCtD
Erlotinib—Headache—Montelukast—asthma	4.79e-05	0.000332	CcSEcCtD
Erlotinib—Mental disorder—Methylprednisolone—asthma	4.78e-05	0.000332	CcSEcCtD
Erlotinib—Erythema—Triamcinolone—asthma	4.76e-05	0.00033	CcSEcCtD
Erlotinib—Malnutrition—Methylprednisolone—asthma	4.75e-05	0.000329	CcSEcCtD
Erlotinib—Erythema—Methylprednisolone—asthma	4.75e-05	0.000329	CcSEcCtD
Erlotinib—Acute coronary syndrome—Prednisone—asthma	4.75e-05	0.000329	CcSEcCtD
Erlotinib—Myocardial infarction—Prednisone—asthma	4.72e-05	0.000327	CcSEcCtD
Erlotinib—Neuropathy peripheral—Prednisone—asthma	4.72e-05	0.000327	CcSEcCtD
Erlotinib—Dizziness—Budesonide—asthma	4.72e-05	0.000327	CcSEcCtD
Erlotinib—Vomiting—Salbutamol—asthma	4.69e-05	0.000325	CcSEcCtD
Erlotinib—Rash—Salbutamol—asthma	4.65e-05	0.000322	CcSEcCtD
Erlotinib—Syncope—Prednisolone—asthma	4.65e-05	0.000322	CcSEcCtD
Erlotinib—Dermatitis—Salbutamol—asthma	4.64e-05	0.000322	CcSEcCtD
Erlotinib—Eye disorder—Betamethasone—asthma	4.64e-05	0.000322	CcSEcCtD
Erlotinib—Eye disorder—Dexamethasone—asthma	4.64e-05	0.000322	CcSEcCtD
Erlotinib—Nausea—Arformoterol—asthma	4.64e-05	0.000321	CcSEcCtD
Erlotinib—Nausea—Formoterol—asthma	4.64e-05	0.000321	CcSEcCtD
Erlotinib—Headache—Salbutamol—asthma	4.62e-05	0.00032	CcSEcCtD
Erlotinib—Back pain—Triamcinolone—asthma	4.61e-05	0.000319	CcSEcCtD
Erlotinib—Loss of consciousness—Prednisolone—asthma	4.55e-05	0.000316	CcSEcCtD
Erlotinib—Nausea—Montelukast—asthma	4.54e-05	0.000315	CcSEcCtD
Erlotinib—Vomiting—Budesonide—asthma	4.54e-05	0.000315	CcSEcCtD
Erlotinib—Syncope—Hydrocortisone—asthma	4.54e-05	0.000314	CcSEcCtD
Erlotinib—Rash—Budesonide—asthma	4.5e-05	0.000312	CcSEcCtD
Erlotinib—Dermatitis—Budesonide—asthma	4.5e-05	0.000312	CcSEcCtD
Erlotinib—Headache—Budesonide—asthma	4.47e-05	0.00031	CcSEcCtD
Erlotinib—Loss of consciousness—Hydrocortisone—asthma	4.45e-05	0.000308	CcSEcCtD
Erlotinib—Arrhythmia—Betamethasone—asthma	4.44e-05	0.000307	CcSEcCtD
Erlotinib—Arrhythmia—Dexamethasone—asthma	4.44e-05	0.000307	CcSEcCtD
Erlotinib—Alopecia—Betamethasone—asthma	4.39e-05	0.000304	CcSEcCtD
Erlotinib—Alopecia—Dexamethasone—asthma	4.39e-05	0.000304	CcSEcCtD
Erlotinib—Nausea—Salbutamol—asthma	4.38e-05	0.000303	CcSEcCtD
Erlotinib—Haemoglobin—Prednisone—asthma	4.35e-05	0.000301	CcSEcCtD
Erlotinib—Haemorrhage—Prednisone—asthma	4.32e-05	0.0003	CcSEcCtD
Erlotinib—Erythema—Dexamethasone—asthma	4.32e-05	0.0003	CcSEcCtD
Erlotinib—Erythema—Betamethasone—asthma	4.32e-05	0.0003	CcSEcCtD
Erlotinib—Myalgia—Hydrocortisone—asthma	4.31e-05	0.000299	CcSEcCtD
Erlotinib—Anxiety—Hydrocortisone—asthma	4.29e-05	0.000297	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	4.28e-05	0.000296	CcSEcCtD
Erlotinib—Syncope—Triamcinolone—asthma	4.27e-05	0.000296	CcSEcCtD
Erlotinib—Syncope—Methylprednisolone—asthma	4.26e-05	0.000295	CcSEcCtD
Erlotinib—Connective tissue disorder—Prednisone—asthma	4.25e-05	0.000295	CcSEcCtD
Erlotinib—Nausea—Budesonide—asthma	4.24e-05	0.000294	CcSEcCtD
Erlotinib—Oedema—Prednisolone—asthma	4.23e-05	0.000293	CcSEcCtD
Erlotinib—Loss of consciousness—Triamcinolone—asthma	4.19e-05	0.00029	CcSEcCtD
Erlotinib—Loss of consciousness—Methylprednisolone—asthma	4.18e-05	0.00029	CcSEcCtD
Erlotinib—Shock—Prednisolone—asthma	4.16e-05	0.000288	CcSEcCtD
Erlotinib—Cough—Triamcinolone—asthma	4.16e-05	0.000288	CcSEcCtD
Erlotinib—Oedema—Hydrocortisone—asthma	4.13e-05	0.000286	CcSEcCtD
Erlotinib—Infection—Hydrocortisone—asthma	4.1e-05	0.000284	CcSEcCtD
Erlotinib—Shock—Hydrocortisone—asthma	4.06e-05	0.000282	CcSEcCtD
Erlotinib—Myalgia—Triamcinolone—asthma	4.06e-05	0.000281	CcSEcCtD
Erlotinib—Nervous system disorder—Hydrocortisone—asthma	4.05e-05	0.000281	CcSEcCtD
Erlotinib—Arthralgia—Methylprednisolone—asthma	4.05e-05	0.00028	CcSEcCtD
Erlotinib—Myalgia—Methylprednisolone—asthma	4.05e-05	0.00028	CcSEcCtD
Erlotinib—Eye disorder—Prednisone—asthma	4.04e-05	0.00028	CcSEcCtD
Erlotinib—Anxiety—Methylprednisolone—asthma	4.03e-05	0.000279	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.02e-05	0.000279	CcSEcCtD
Erlotinib—Skin disorder—Hydrocortisone—asthma	4.01e-05	0.000278	CcSEcCtD
Erlotinib—Anorexia—Hydrocortisone—asthma	3.94e-05	0.000273	CcSEcCtD
Erlotinib—Oedema—Triamcinolone—asthma	3.89e-05	0.000269	CcSEcCtD
Erlotinib—Syncope—Dexamethasone—asthma	3.88e-05	0.000269	CcSEcCtD
Erlotinib—Syncope—Betamethasone—asthma	3.88e-05	0.000269	CcSEcCtD
Erlotinib—Arrhythmia—Prednisone—asthma	3.86e-05	0.000268	CcSEcCtD
Erlotinib—Infection—Triamcinolone—asthma	3.86e-05	0.000268	CcSEcCtD
Erlotinib—Infection—Methylprednisolone—asthma	3.85e-05	0.000267	CcSEcCtD
Erlotinib—Shock—Triamcinolone—asthma	3.83e-05	0.000265	CcSEcCtD
Erlotinib—Insomnia—Prednisolone—asthma	3.82e-05	0.000265	CcSEcCtD
Erlotinib—Alopecia—Prednisone—asthma	3.82e-05	0.000265	CcSEcCtD
Erlotinib—Shock—Methylprednisolone—asthma	3.82e-05	0.000265	CcSEcCtD
Erlotinib—Nervous system disorder—Methylprednisolone—asthma	3.8e-05	0.000264	CcSEcCtD
Erlotinib—Loss of consciousness—Dexamethasone—asthma	3.8e-05	0.000263	CcSEcCtD
Erlotinib—Loss of consciousness—Betamethasone—asthma	3.8e-05	0.000263	CcSEcCtD
Erlotinib—Mental disorder—Prednisone—asthma	3.79e-05	0.000263	CcSEcCtD
Erlotinib—Skin disorder—Methylprednisolone—asthma	3.77e-05	0.000261	CcSEcCtD
Erlotinib—Erythema—Prednisone—asthma	3.76e-05	0.000261	CcSEcCtD
Erlotinib—Malnutrition—Prednisone—asthma	3.76e-05	0.000261	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Hydrocortisone—asthma	3.76e-05	0.000261	CcSEcCtD
Erlotinib—Insomnia—Hydrocortisone—asthma	3.73e-05	0.000259	CcSEcCtD
Erlotinib—Myalgia—Dexamethasone—asthma	3.68e-05	0.000255	CcSEcCtD
Erlotinib—Myalgia—Betamethasone—asthma	3.68e-05	0.000255	CcSEcCtD
Erlotinib—Anxiety—Dexamethasone—asthma	3.67e-05	0.000254	CcSEcCtD
Erlotinib—Anxiety—Betamethasone—asthma	3.67e-05	0.000254	CcSEcCtD
Erlotinib—Dyspepsia—Hydrocortisone—asthma	3.63e-05	0.000252	CcSEcCtD
Erlotinib—Pain—Prednisolone—asthma	3.62e-05	0.000251	CcSEcCtD
Erlotinib—Decreased appetite—Hydrocortisone—asthma	3.59e-05	0.000249	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Hydrocortisone—asthma	3.56e-05	0.000247	CcSEcCtD
Erlotinib—Fatigue—Hydrocortisone—asthma	3.56e-05	0.000247	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Triamcinolone—asthma	3.54e-05	0.000245	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Methylprednisolone—asthma	3.53e-05	0.000245	CcSEcCtD
Erlotinib—Pain—Hydrocortisone—asthma	3.53e-05	0.000245	CcSEcCtD
Erlotinib—Oedema—Dexamethasone—asthma	3.53e-05	0.000244	CcSEcCtD
Erlotinib—Oedema—Betamethasone—asthma	3.53e-05	0.000244	CcSEcCtD
Erlotinib—Insomnia—Triamcinolone—asthma	3.52e-05	0.000244	CcSEcCtD
Erlotinib—Insomnia—Methylprednisolone—asthma	3.51e-05	0.000243	CcSEcCtD
Erlotinib—Infection—Dexamethasone—asthma	3.5e-05	0.000243	CcSEcCtD
Erlotinib—Infection—Betamethasone—asthma	3.5e-05	0.000243	CcSEcCtD
Erlotinib—Shock—Dexamethasone—asthma	3.47e-05	0.000241	CcSEcCtD
Erlotinib—Shock—Betamethasone—asthma	3.47e-05	0.000241	CcSEcCtD
Erlotinib—Dyspnoea—Triamcinolone—asthma	3.47e-05	0.00024	CcSEcCtD
Erlotinib—Nervous system disorder—Betamethasone—asthma	3.46e-05	0.00024	CcSEcCtD
Erlotinib—Nervous system disorder—Dexamethasone—asthma	3.46e-05	0.00024	CcSEcCtD
Erlotinib—Thrombocytopenia—Betamethasone—asthma	3.45e-05	0.000239	CcSEcCtD
Erlotinib—Thrombocytopenia—Dexamethasone—asthma	3.45e-05	0.000239	CcSEcCtD
Erlotinib—Dyspepsia—Triamcinolone—asthma	3.42e-05	0.000237	CcSEcCtD
Erlotinib—Dyspepsia—Methylprednisolone—asthma	3.41e-05	0.000237	CcSEcCtD
Erlotinib—Gastrointestinal pain—Hydrocortisone—asthma	3.38e-05	0.000234	CcSEcCtD
Erlotinib—Syncope—Prednisone—asthma	3.38e-05	0.000234	CcSEcCtD
Erlotinib—Anorexia—Betamethasone—asthma	3.36e-05	0.000233	CcSEcCtD
Erlotinib—Anorexia—Dexamethasone—asthma	3.36e-05	0.000233	CcSEcCtD
Erlotinib—Fatigue—Triamcinolone—asthma	3.35e-05	0.000232	CcSEcCtD
Erlotinib—Fatigue—Methylprednisolone—asthma	3.34e-05	0.000232	CcSEcCtD
Erlotinib—Pain—Triamcinolone—asthma	3.32e-05	0.00023	CcSEcCtD
Erlotinib—Loss of consciousness—Prednisone—asthma	3.31e-05	0.000229	CcSEcCtD
Erlotinib—Abdominal pain—Hydrocortisone—asthma	3.26e-05	0.000226	CcSEcCtD
Erlotinib—Body temperature increased—Hydrocortisone—asthma	3.26e-05	0.000226	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Betamethasone—asthma	3.21e-05	0.000223	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Dexamethasone—asthma	3.21e-05	0.000223	CcSEcCtD
Erlotinib—Arthralgia—Prednisone—asthma	3.2e-05	0.000222	CcSEcCtD
Erlotinib—Myalgia—Prednisone—asthma	3.2e-05	0.000222	CcSEcCtD
Erlotinib—Anxiety—Prednisone—asthma	3.19e-05	0.000221	CcSEcCtD
Erlotinib—Insomnia—Dexamethasone—asthma	3.19e-05	0.000221	CcSEcCtD
Erlotinib—Insomnia—Betamethasone—asthma	3.19e-05	0.000221	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.18e-05	0.000221	CcSEcCtD
Erlotinib—Gastrointestinal pain—Methylprednisolone—asthma	3.17e-05	0.00022	CcSEcCtD
Erlotinib—Dyspepsia—Dexamethasone—asthma	3.11e-05	0.000215	CcSEcCtD
Erlotinib—Dyspepsia—Betamethasone—asthma	3.11e-05	0.000215	CcSEcCtD
Erlotinib—Body temperature increased—Triamcinolone—asthma	3.07e-05	0.000213	CcSEcCtD
Erlotinib—Oedema—Prednisone—asthma	3.07e-05	0.000213	CcSEcCtD
Erlotinib—Abdominal pain—Methylprednisolone—asthma	3.07e-05	0.000213	CcSEcCtD
Erlotinib—Decreased appetite—Dexamethasone—asthma	3.07e-05	0.000213	CcSEcCtD
Erlotinib—Decreased appetite—Betamethasone—asthma	3.07e-05	0.000213	CcSEcCtD
Erlotinib—Infection—Prednisone—asthma	3.05e-05	0.000212	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Betamethasone—asthma	3.05e-05	0.000211	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Dexamethasone—asthma	3.05e-05	0.000211	CcSEcCtD
Erlotinib—Fatigue—Dexamethasone—asthma	3.04e-05	0.000211	CcSEcCtD
Erlotinib—Fatigue—Betamethasone—asthma	3.04e-05	0.000211	CcSEcCtD
Erlotinib—Shock—Prednisone—asthma	3.02e-05	0.000209	CcSEcCtD
Erlotinib—Pain—Dexamethasone—asthma	3.02e-05	0.000209	CcSEcCtD
Erlotinib—Pain—Betamethasone—asthma	3.02e-05	0.000209	CcSEcCtD
Erlotinib—Nervous system disorder—Prednisone—asthma	3.01e-05	0.000209	CcSEcCtD
Erlotinib—Skin disorder—Prednisone—asthma	2.98e-05	0.000207	CcSEcCtD
Erlotinib—Asthenia—Hydrocortisone—asthma	2.96e-05	0.000205	CcSEcCtD
Erlotinib—Anorexia—Prednisone—asthma	2.93e-05	0.000203	CcSEcCtD
Erlotinib—Pruritus—Hydrocortisone—asthma	2.92e-05	0.000202	CcSEcCtD
Erlotinib—Gastrointestinal pain—Dexamethasone—asthma	2.88e-05	0.0002	CcSEcCtD
Erlotinib—Gastrointestinal pain—Betamethasone—asthma	2.88e-05	0.0002	CcSEcCtD
Erlotinib—Diarrhoea—Hydrocortisone—asthma	2.83e-05	0.000196	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Prednisone—asthma	2.8e-05	0.000194	CcSEcCtD
Erlotinib—Dizziness—Prednisolone—asthma	2.8e-05	0.000194	CcSEcCtD
Erlotinib—Asthenia—Triamcinolone—asthma	2.79e-05	0.000193	CcSEcCtD
Erlotinib—Abdominal pain—Dexamethasone—asthma	2.79e-05	0.000193	CcSEcCtD
Erlotinib—Body temperature increased—Betamethasone—asthma	2.79e-05	0.000193	CcSEcCtD
Erlotinib—Body temperature increased—Dexamethasone—asthma	2.79e-05	0.000193	CcSEcCtD
Erlotinib—Abdominal pain—Betamethasone—asthma	2.79e-05	0.000193	CcSEcCtD
Erlotinib—Asthenia—Methylprednisolone—asthma	2.78e-05	0.000193	CcSEcCtD
Erlotinib—Insomnia—Prednisone—asthma	2.78e-05	0.000193	CcSEcCtD
Erlotinib—Pruritus—Triamcinolone—asthma	2.75e-05	0.000191	CcSEcCtD
Erlotinib—Pruritus—Methylprednisolone—asthma	2.74e-05	0.00019	CcSEcCtD
Erlotinib—Dizziness—Hydrocortisone—asthma	2.73e-05	0.000189	CcSEcCtD
Erlotinib—Dyspepsia—Prednisone—asthma	2.7e-05	0.000187	CcSEcCtD
Erlotinib—Decreased appetite—Prednisone—asthma	2.67e-05	0.000185	CcSEcCtD
Erlotinib—Rash—Prednisolone—asthma	2.67e-05	0.000185	CcSEcCtD
Erlotinib—Dermatitis—Prednisolone—asthma	2.66e-05	0.000185	CcSEcCtD
Erlotinib—Diarrhoea—Methylprednisolone—asthma	2.65e-05	0.000184	CcSEcCtD
Erlotinib—Fatigue—Prednisone—asthma	2.65e-05	0.000184	CcSEcCtD
Erlotinib—Headache—Prednisolone—asthma	2.65e-05	0.000184	CcSEcCtD
Erlotinib—Constipation—Prednisone—asthma	2.63e-05	0.000182	CcSEcCtD
Erlotinib—Vomiting—Hydrocortisone—asthma	2.63e-05	0.000182	CcSEcCtD
Erlotinib—Rash—Hydrocortisone—asthma	2.6e-05	0.00018	CcSEcCtD
Erlotinib—Dermatitis—Hydrocortisone—asthma	2.6e-05	0.00018	CcSEcCtD
Erlotinib—Headache—Hydrocortisone—asthma	2.59e-05	0.000179	CcSEcCtD
Erlotinib—Dizziness—Triamcinolone—asthma	2.57e-05	0.000178	CcSEcCtD
Erlotinib—Dizziness—Methylprednisolone—asthma	2.57e-05	0.000178	CcSEcCtD
Erlotinib—Asthenia—Dexamethasone—asthma	2.53e-05	0.000175	CcSEcCtD
Erlotinib—Asthenia—Betamethasone—asthma	2.53e-05	0.000175	CcSEcCtD
Erlotinib—Gastrointestinal pain—Prednisone—asthma	2.51e-05	0.000174	CcSEcCtD
Erlotinib—Nausea—Prednisolone—asthma	2.51e-05	0.000174	CcSEcCtD
Erlotinib—Pruritus—Dexamethasone—asthma	2.5e-05	0.000173	CcSEcCtD
Erlotinib—Pruritus—Betamethasone—asthma	2.5e-05	0.000173	CcSEcCtD
Erlotinib—Vomiting—Triamcinolone—asthma	2.47e-05	0.000171	CcSEcCtD
Erlotinib—Vomiting—Methylprednisolone—asthma	2.47e-05	0.000171	CcSEcCtD
Erlotinib—Nausea—Hydrocortisone—asthma	2.45e-05	0.00017	CcSEcCtD
Erlotinib—Rash—Triamcinolone—asthma	2.45e-05	0.00017	CcSEcCtD
Erlotinib—Dermatitis—Triamcinolone—asthma	2.45e-05	0.00017	CcSEcCtD
Erlotinib—Rash—Methylprednisolone—asthma	2.45e-05	0.00017	CcSEcCtD
Erlotinib—Dermatitis—Methylprednisolone—asthma	2.44e-05	0.000169	CcSEcCtD
Erlotinib—Headache—Triamcinolone—asthma	2.44e-05	0.000169	CcSEcCtD
Erlotinib—Headache—Methylprednisolone—asthma	2.43e-05	0.000168	CcSEcCtD
Erlotinib—Abdominal pain—Prednisone—asthma	2.43e-05	0.000168	CcSEcCtD
Erlotinib—Body temperature increased—Prednisone—asthma	2.43e-05	0.000168	CcSEcCtD
Erlotinib—Diarrhoea—Dexamethasone—asthma	2.41e-05	0.000167	CcSEcCtD
Erlotinib—Diarrhoea—Betamethasone—asthma	2.41e-05	0.000167	CcSEcCtD
Erlotinib—Dizziness—Dexamethasone—asthma	2.33e-05	0.000162	CcSEcCtD
Erlotinib—Dizziness—Betamethasone—asthma	2.33e-05	0.000162	CcSEcCtD
Erlotinib—Nausea—Triamcinolone—asthma	2.31e-05	0.00016	CcSEcCtD
Erlotinib—Nausea—Methylprednisolone—asthma	2.3e-05	0.00016	CcSEcCtD
Erlotinib—Vomiting—Betamethasone—asthma	2.24e-05	0.000155	CcSEcCtD
Erlotinib—Vomiting—Dexamethasone—asthma	2.24e-05	0.000155	CcSEcCtD
Erlotinib—Rash—Betamethasone—asthma	2.22e-05	0.000154	CcSEcCtD
Erlotinib—Rash—Dexamethasone—asthma	2.22e-05	0.000154	CcSEcCtD
Erlotinib—Dermatitis—Dexamethasone—asthma	2.22e-05	0.000154	CcSEcCtD
Erlotinib—Dermatitis—Betamethasone—asthma	2.22e-05	0.000154	CcSEcCtD
Erlotinib—Headache—Betamethasone—asthma	2.21e-05	0.000153	CcSEcCtD
Erlotinib—Headache—Dexamethasone—asthma	2.21e-05	0.000153	CcSEcCtD
Erlotinib—Asthenia—Prednisone—asthma	2.2e-05	0.000153	CcSEcCtD
Erlotinib—Pruritus—Prednisone—asthma	2.17e-05	0.000151	CcSEcCtD
Erlotinib—Diarrhoea—Prednisone—asthma	2.1e-05	0.000146	CcSEcCtD
Erlotinib—Nausea—Betamethasone—asthma	2.1e-05	0.000145	CcSEcCtD
Erlotinib—Nausea—Dexamethasone—asthma	2.1e-05	0.000145	CcSEcCtD
Erlotinib—Dizziness—Prednisone—asthma	2.03e-05	0.000141	CcSEcCtD
Erlotinib—Vomiting—Prednisone—asthma	1.95e-05	0.000135	CcSEcCtD
Erlotinib—Rash—Prednisone—asthma	1.94e-05	0.000134	CcSEcCtD
Erlotinib—Dermatitis—Prednisone—asthma	1.94e-05	0.000134	CcSEcCtD
Erlotinib—Headache—Prednisone—asthma	1.92e-05	0.000133	CcSEcCtD
Erlotinib—Nausea—Prednisone—asthma	1.82e-05	0.000126	CcSEcCtD
Erlotinib—ABL1—Developmental Biology—IL6—asthma	3.65e-06	4.09e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—BCL2—asthma	3.63e-06	4.07e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ITPR1—asthma	3.62e-06	4.05e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6R—asthma	3.6e-06	4.04e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IFNG—asthma	3.59e-06	4.03e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—RHOA—asthma	3.57e-06	4.01e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—RHOA—asthma	3.56e-06	3.99e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—NOS3—asthma	3.54e-06	3.97e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NQO1—asthma	3.52e-06	3.95e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CARM1—asthma	3.51e-06	3.94e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PPP2CA—asthma	3.47e-06	3.89e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD4—asthma	3.47e-06	3.89e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALOX5—asthma	3.47e-06	3.89e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—DCN—asthma	3.46e-06	3.88e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALOX5AP—asthma	3.45e-06	3.87e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALOX15—asthma	3.45e-06	3.87e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ADCY2—asthma	3.45e-06	3.87e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CD86—asthma	3.44e-06	3.86e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CXCL8—asthma	3.44e-06	3.86e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—VEGFA—asthma	3.43e-06	3.84e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—EDN1—asthma	3.42e-06	3.83e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—STAT3—asthma	3.39e-06	3.81e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL5—asthma	3.39e-06	3.8e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—asthma	3.38e-06	3.8e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PLA2G4A—asthma	3.38e-06	3.79e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ALDH2—asthma	3.36e-06	3.77e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALDH7A1—asthma	3.35e-06	3.76e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CSF2—asthma	3.34e-06	3.74e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NQO1—asthma	3.33e-06	3.73e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6R—asthma	3.32e-06	3.73e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CARM1—asthma	3.31e-06	3.71e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CHAT—asthma	3.29e-06	3.69e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL2—asthma	3.29e-06	3.69e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—DCN—asthma	3.26e-06	3.65e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ADCY2—asthma	3.26e-06	3.65e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SMAD3—asthma	3.25e-06	3.64e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—asthma	3.23e-06	3.62e-05	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—IL6—asthma	3.22e-06	3.61e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ARG2—asthma	3.22e-06	3.61e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1B—asthma	3.21e-06	3.59e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GSTT1—asthma	3.2e-06	3.59e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL2—asthma	3.19e-06	3.58e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALDH2—asthma	3.17e-06	3.56e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TGFB1—asthma	3.15e-06	3.53e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL6—asthma	3.14e-06	3.53e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—POMC—asthma	3.14e-06	3.52e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CXCL8—asthma	3.12e-06	3.5e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—IL6—asthma	3.12e-06	3.5e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—SERPINE1—asthma	3.11e-06	3.49e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MMP9—asthma	3.11e-06	3.49e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PPP2CA—asthma	3.11e-06	3.49e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—BCL2—asthma	3.1e-06	3.48e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—PTEN—asthma	3.09e-06	3.47e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—EGFR—asthma	3.08e-06	3.46e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IFNG—asthma	3.07e-06	3.44e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCR5—asthma	3.05e-06	3.42e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NQO1—asthma	3.05e-06	3.42e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NQO1—asthma	3.03e-06	3.4e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GSTT1—asthma	3.01e-06	3.38e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL2RA—asthma	3.01e-06	3.37e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—PTEN—asthma	3e-06	3.37e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—RHOA—asthma	3e-06	3.37e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—IL2—asthma	3e-06	3.36e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ADCY2—asthma	2.99e-06	3.35e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL2—asthma	2.99e-06	3.35e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—C3—asthma	2.98e-06	3.35e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS3—asthma	2.97e-06	3.33e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ADCY2—asthma	2.97e-06	3.33e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD4—asthma	2.97e-06	3.33e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.96e-06	3.32e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.94e-06	3.3e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GSTP1—asthma	2.94e-06	3.3e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALOX5—asthma	2.94e-06	3.29e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—POMC—asthma	2.93e-06	3.28e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PDGFB—asthma	2.9e-06	3.26e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—HMOX1—asthma	2.9e-06	3.25e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ITPR1—asthma	2.89e-06	3.24e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ALB—asthma	2.86e-06	3.21e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CAT—asthma	2.86e-06	3.21e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—asthma	2.82e-06	3.16e-05	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ALB—asthma	2.8e-06	3.14e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CARM1—asthma	2.8e-06	3.14e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—VEGFA—asthma	2.79e-06	3.13e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—LEP—asthma	2.78e-06	3.12e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GSTP1—asthma	2.78e-06	3.11e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—STAT3—asthma	2.77e-06	3.1e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—DCN—asthma	2.76e-06	3.1e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—IL6—asthma	2.75e-06	3.09e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1B—asthma	2.74e-06	3.07e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—NOS3—asthma	2.74e-06	3.07e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—HMOX1—asthma	2.74e-06	3.07e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD4—asthma	2.74e-06	3.07e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ITPR1—asthma	2.73e-06	3.06e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL2—asthma	2.73e-06	3.06e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTGS2—asthma	2.72e-06	3.05e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CAT—asthma	2.7e-06	3.03e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PLA2G4A—asthma	2.7e-06	3.03e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GSTM1—asthma	2.7e-06	3.03e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—STAT3—asthma	2.69e-06	3.01e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALDH2—asthma	2.69e-06	3.01e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ALB—asthma	2.67e-06	2.99e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALOX15—asthma	2.66e-06	2.99e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALOX5AP—asthma	2.66e-06	2.99e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—POMC—asthma	2.66e-06	2.99e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NQO1—asthma	2.66e-06	2.98e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—FN1—asthma	2.62e-06	2.94e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ADCY2—asthma	2.6e-06	2.92e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	2.58e-06	2.9e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—asthma	2.58e-06	2.9e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTEN—asthma	2.57e-06	2.88e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—PTEN—asthma	2.57e-06	2.88e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TGFB1—asthma	2.56e-06	2.88e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GSTT1—asthma	2.55e-06	2.86e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—NOS3—asthma	2.55e-06	2.86e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GSTM1—asthma	2.55e-06	2.86e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PLA2G4A—asthma	2.55e-06	2.86e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—VEGFA—asthma	2.55e-06	2.86e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GSTP1—asthma	2.55e-06	2.86e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CHAT—asthma	2.54e-06	2.85e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GSTP1—asthma	2.53e-06	2.84e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—EGFR—asthma	2.51e-06	2.82e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—HMOX1—asthma	2.51e-06	2.82e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NQO1—asthma	2.51e-06	2.81e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ITPR1—asthma	2.5e-06	2.81e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGS2—asthma	2.5e-06	2.81e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—HMOX1—asthma	2.5e-06	2.8e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ITPR1—asthma	2.49e-06	2.79e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPP2CA—asthma	2.49e-06	2.79e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CAT—asthma	2.48e-06	2.78e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CAT—asthma	2.46e-06	2.76e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ADCY2—asthma	2.45e-06	2.75e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—EGFR—asthma	2.44e-06	2.74e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ALB—asthma	2.43e-06	2.72e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—POMC—asthma	2.39e-06	2.68e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL6—asthma	2.37e-06	2.66e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTEN—asthma	2.37e-06	2.66e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—asthma	2.35e-06	2.64e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPP2CA—asthma	2.35e-06	2.64e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PLA2G4A—asthma	2.34e-06	2.62e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GSTM1—asthma	2.34e-06	2.62e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TGFB1—asthma	2.34e-06	2.62e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS2—asthma	2.34e-06	2.62e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL2—asthma	2.33e-06	2.62e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6R—asthma	2.33e-06	2.61e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PLA2G4A—asthma	2.33e-06	2.61e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GSTM1—asthma	2.33e-06	2.61e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—NOS3—asthma	2.32e-06	2.61e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—STAT3—asthma	2.3e-06	2.58e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALOX5—asthma	2.27e-06	2.54e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GSTP1—asthma	2.22e-06	2.49e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—HMOX1—asthma	2.19e-06	2.45e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTEN—asthma	2.18e-06	2.45e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ITPR1—asthma	2.18e-06	2.45e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SERPINE1—asthma	2.18e-06	2.44e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CARM1—asthma	2.16e-06	2.42e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CAT—asthma	2.16e-06	2.42e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPP2CA—asthma	2.15e-06	2.42e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPP2CA—asthma	2.14e-06	2.4e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DCN—asthma	2.13e-06	2.39e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—asthma	2.13e-06	2.38e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NQO1—asthma	2.12e-06	2.38e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—STAT3—asthma	2.12e-06	2.38e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RHOA—asthma	2.1e-06	2.36e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GSTP1—asthma	2.09e-06	2.34e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NOS3—asthma	2.08e-06	2.33e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ADCY2—asthma	2.08e-06	2.33e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALDH2—asthma	2.07e-06	2.32e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—HMOX1—asthma	2.06e-06	2.31e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.06e-06	2.31e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ITPR1—asthma	2.06e-06	2.31e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PLA2G4A—asthma	2.04e-06	2.29e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GSTM1—asthma	2.04e-06	2.29e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTEN—asthma	2.04e-06	2.28e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CAT—asthma	2.03e-06	2.28e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GSTT1—asthma	1.97e-06	2.21e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFB1—asthma	1.97e-06	2.2e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—asthma	1.93e-06	2.17e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PLA2G4A—asthma	1.92e-06	2.15e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GSTM1—asthma	1.92e-06	2.15e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—POMC—asthma	1.91e-06	2.14e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPP2CA—asthma	1.88e-06	2.11e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—asthma	1.88e-06	2.11e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTEN—asthma	1.85e-06	2.08e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL8—asthma	1.85e-06	2.07e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—POMC—asthma	1.8e-06	2.02e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—asthma	1.8e-06	2.01e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GSTP1—asthma	1.77e-06	1.99e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPP2CA—asthma	1.77e-06	1.98e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL2—asthma	1.76e-06	1.98e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—asthma	1.76e-06	1.97e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—HMOX1—asthma	1.75e-06	1.96e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ITPR1—asthma	1.74e-06	1.95e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ALB—asthma	1.74e-06	1.95e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CAT—asthma	1.72e-06	1.93e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP9—asthma	1.67e-06	1.87e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NOS3—asthma	1.66e-06	1.87e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PTEN—asthma	1.66e-06	1.86e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—POMC—asthma	1.65e-06	1.85e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ALB—asthma	1.64e-06	1.84e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—POMC—asthma	1.64e-06	1.84e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NQO1—asthma	1.64e-06	1.84e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GSTM1—asthma	1.63e-06	1.82e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PLA2G4A—asthma	1.63e-06	1.82e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—asthma	1.6e-06	1.8e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ADCY2—asthma	1.6e-06	1.8e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NOS3—asthma	1.57e-06	1.76e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—asthma	1.52e-06	1.71e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ALB—asthma	1.51e-06	1.69e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—VEGFA—asthma	1.5e-06	1.68e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPP2CA—asthma	1.5e-06	1.68e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—STAT3—asthma	1.48e-06	1.66e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—asthma	1.48e-06	1.66e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NOS3—asthma	1.44e-06	1.62e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—POMC—asthma	1.44e-06	1.62e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—asthma	1.44e-06	1.61e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NOS3—asthma	1.43e-06	1.61e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFB1—asthma	1.38e-06	1.54e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GSTP1—asthma	1.37e-06	1.53e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—POMC—asthma	1.36e-06	1.52e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HMOX1—asthma	1.35e-06	1.51e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ITPR1—asthma	1.34e-06	1.51e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CAT—asthma	1.33e-06	1.49e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTEN—asthma	1.33e-06	1.49e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—asthma	1.32e-06	1.48e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ALB—asthma	1.31e-06	1.47e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—asthma	1.31e-06	1.47e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NOS3—asthma	1.26e-06	1.41e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PLA2G4A—asthma	1.26e-06	1.41e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GSTM1—asthma	1.26e-06	1.41e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTEN—asthma	1.25e-06	1.41e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALB—asthma	1.24e-06	1.39e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NOS3—asthma	1.18e-06	1.33e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPP2CA—asthma	1.16e-06	1.3e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTEN—asthma	1.15e-06	1.29e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—POMC—asthma	1.15e-06	1.29e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—asthma	1.15e-06	1.29e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTEN—asthma	1.14e-06	1.28e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—asthma	1.08e-06	1.21e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALB—asthma	1.05e-06	1.18e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—asthma	1.04e-06	1.16e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NOS3—asthma	1e-06	1.12e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTEN—asthma	1e-06	1.12e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTEN—asthma	9.44e-07	1.06e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—asthma	9.17e-07	1.03e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—POMC—asthma	8.87e-07	9.95e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALB—asthma	8.09e-07	9.07e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTEN—asthma	8e-07	8.97e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NOS3—asthma	7.74e-07	8.68e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—asthma	7.08e-07	7.94e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTEN—asthma	6.17e-07	6.92e-06	CbGpPWpGaD
